Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis

被引:86
作者
Zulian, F
Martini, G
Gobber, D
Agosto, C
Gigante, C
Zacchello, F
机构
[1] Univ Padua, Dept Paediat, Paediat Rheumatol Unit, I-35128 Padua, Italy
[2] Univ Padua, Dept Orthopaed, I-35128 Padua, Italy
关键词
juvenile idiopathic arthritis; intra-articular corticosteroids; triamcinolone;
D O I
10.1093/rheumatology/keg358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare the efficacy and safety of intra-articular triamcinolone hexacetonide (TH) and triamcinolone acetonide (TA) in children with oligoarticular juvenile idiopathic arthritis (JIA). Methods. One hundred and thirty joints of 85 patients undergoing intra-articular injections were randomly treated with either TH or TA depending on the availability of the drug. The efficacy of both treatments was evaluated prospectively in a blinded fashion. A good response was defined as a decrease in the articular score of greater than or equal to60% from baseline. Clinical, laboratory and immunological variables were noted in order to examine possible factors, other than treatment, predictive of the result. Results. Seventy injections were performed using TH and 60 with TA. The two groups were comparable for clinical, immunological and laboratory characteristics. The rate of response was significantly higher with TH than with TA: 81.4% vs 53.3% (P = 0.001) at 6 months, 67.1 vs 43.3% (P = 0.006) at 12 months, and 60 vs 33.3% (P = 0.002) at 24 months. Conclusion. At comparable doses TH appeared to be much more effective than TA for intra-articular use, in both short- and long-term follow-up. This result was not affected by disease duration or degree of local and systemic inflammation.
引用
收藏
页码:1254 / 1259
页数:6
相关论文
共 26 条
[1]   INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE IN THE MANAGEMENT OF CHRONIC ARTHRITIS IN CHILDREN [J].
ALLEN, RC ;
GROSS, KR ;
LAXER, RM ;
MALLESON, PN ;
BEAUCHAMP, RD ;
PETTY, RE .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :997-1001
[2]  
BALOGH Z, 1988, SCAND J RHEUMATOL S, V67, P80
[3]   Anti-inflammatory actions of glucocorticoids: molecular mechanisms [J].
Barnes, PJ .
CLINICAL SCIENCE, 1998, 94 (06) :557-572
[4]  
BLYTH T, 1994, BRIT J RHEUMATOL, V33, P461
[5]   Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].
Boers, M ;
Verhoeven, AC ;
Markusse, HM ;
vandeLaar, MAFJ ;
Westhovens, R ;
vanDenderen, JC ;
vanZeben, D ;
Dijkmans, BAC ;
Peeters, AJ ;
Jacobs, P ;
vandenBrink, HR ;
Schouten, HJA ;
vanderHeijde, DMFM ;
Boonen, A ;
vanderLinden, S .
LANCET, 1997, 350 (9074) :309-318
[6]  
Breit W, 2000, J RHEUMATOL, V27, P2696
[7]  
Centeno L M, 1994, Arthritis Care Res, V7, P151, DOI 10.1002/art.1790070309
[8]  
Dent Peter B., 1998, Current Opinion in Rheumatology, V10, P475, DOI 10.1097/00002281-199809000-00013
[9]   PHARMACOKINETICS AND PHARMACODYNAMICS OF GLUCOCORTICOID SUSPENSIONS AFTER INTRAARTICULAR ADMINISTRATION [J].
DERENDORF, H ;
MOLLMANN, H ;
GRUNER, A ;
HAACK, D ;
GYSELBY, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (03) :313-317
[10]  
EARLEY A, 1988, CLIN EXP RHEUMATOL, V6, P153